BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25782631)

  • 1. Spinal vasopressin alleviates formalin-induced nociception by enhancing GABAA receptor function in mice.
    Peng F; Qu ZW; Qiu CY; Liao M; Hu WP
    Neurosci Lett; 2015 Apr; 593():61-5. PubMed ID: 25782631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neurons.
    Qiu F; Qiu CY; Cai H; Liu TT; Qu ZW; Yang Z; Li JD; Zhou QY; Hu WP
    Br J Pharmacol; 2014 Jun; 171(12):3065-76. PubMed ID: 24641084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of peripheral vasopressin 1A and oxytocin receptors on the subcutaneous vasopressin antinociceptive effects.
    Manzano-García A; González-Hernández A; Tello-García IA; Martínez-Lorenzana G; Condés-Lara M
    Eur J Pain; 2018 Mar; 22(3):511-526. PubMed ID: 29082571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats.
    Juif PE; Poisbeau P
    Pain; 2013 Aug; 154(8):1449-56. PubMed ID: 23707282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse.
    Schorscher-Petcu A; Sotocinal S; Ciura S; Dupré A; Ritchie J; Sorge RE; Crawley JN; Hu SB; Nishimori K; Young LJ; Tribollet E; Quirion R; Mogil JS
    J Neurosci; 2010 Jun; 30(24):8274-84. PubMed ID: 20554879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal RGS4 inhibitor, CCG50014, reduces nociceptive responses and enhances opioid-mediated analgesic effects in the mouse formalin test.
    Yoon SY; Woo J; Park JO; Choi EJ; Shin HS; Roh DH; Kim KS
    Anesth Analg; 2015 Mar; 120(3):671-677. PubMed ID: 25695583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of GABA-activated currents by arginine vasopressin in rat dorsal root ganglion neurons.
    Qiu F; Hu WP; Yang ZF
    Sheng Li Xue Bao; 2014 Dec; 66(6):647-57. PubMed ID: 25516513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the participation of peripheral α5 subunit-containing GABAA receptors in GABAA agonists-induced nociception in rats.
    Bravo-Hernández M; Feria-Morales LA; Torres-López JE; Cervantes-Durán C; Delgado-Lezama R; Granados-Soto V; Rocha-González HI
    Eur J Pharmacol; 2014 Jul; 734():91-7. PubMed ID: 24726872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
    Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones.
    Gouzénes L; Sabatier N; Richard P; Moos FC; Dayanithi G
    J Physiol; 1999 Jun; 517 ( Pt 3)(Pt 3):771-9. PubMed ID: 10358117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modulatory effect of nitric oxide in pro- and anti-convulsive effects of vasopressin in PTZ-induced seizures threshold in mice.
    Javadian N; Rahimi N; Javadi-Paydar M; Doustimotlagh AH; Dehpour AR
    Epilepsy Res; 2016 Oct; 126():134-40. PubMed ID: 27497813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired arginine-vasopressin-induced aldosterone release from adrenal gland cells in mice lacking the vasopressin V1A receptor.
    Birumachi J; Hiroyama M; Fujiwara Y; Aoyagi T; Sanbe A; Tanoue A
    Eur J Pharmacol; 2007 Jul; 566(1-3):226-30. PubMed ID: 17449028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxysophoridine through intrathecal injection induces antinociception and increases the expression of the GABAAα1 receptor in the spinal cord of mice.
    Yang G; Gao J; Jia Y; Yan L; Yu J; Jiang Y
    Planta Med; 2012 Jun; 78(9):874-80. PubMed ID: 22532023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of arginine vasopressin in the nucleus raphe magnus on antinociception in the rat.
    Yang J; Chen JM; Liu WY; Song CY; Wang CH; Lin BC
    Peptides; 2006 Sep; 27(9):2224-9. PubMed ID: 16621154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of arginine vasopressin receptor 1a facilitates the induction of long-term potentiation in the accessory olfactory bulb of male mice.
    Namba T; Taniguchi M; Murata Y; Tong J; Wang Y; Okutani F; Yamaguchi M; Kaba H
    Neurosci Lett; 2016 Nov; 634():107-113. PubMed ID: 27697521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V
    Taveau C; Chollet C; Bichet DG; Velho G; Guillon G; Corbani M; Roussel R; Bankir L; Melander O; Bouby N
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E127-E135. PubMed ID: 27998960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute inflammation reveals GABA
    Jang IJ; Davies AJ; Akimoto N; Back SK; Lee PR; Na HS; Furue H; Jung SJ; Kim YH; Oh SB
    Physiol Rep; 2017 Apr; 5(8):. PubMed ID: 28438981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological enhancement of δ-subunit-containing GABA(A) receptors that generate a tonic inhibitory conductance in spinal neurons attenuates acute nociception in mice.
    Bonin RP; Labrakakis C; Eng DG; Whissell PD; De Koninck Y; Orser BA
    Pain; 2011 Jun; 152(6):1317-1326. PubMed ID: 21396779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
    Oshikawa S; Tanoue A; Koshimizu TA; Kitagawa Y; Tsujimoto G
    Mol Pharmacol; 2004 Mar; 65(3):623-9. PubMed ID: 14978240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine8-vasopressin reduces spinal cord blood flow after spinal subarachnoid injection in rats.
    Long JB; Martinez-Arizala A; Johnson SH; Holaday JW
    J Pharmacol Exp Ther; 1989 May; 249(2):499-506. PubMed ID: 2524587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.